China Chemical Regulatory China International Trade & Investment Government Affairs & Public Policy
ISLN:
909931467
Admitted:
Chinese National Bar
Law School:
Nanjing University in Nanjing, China, LL.B., 1993; Shanghai Academy of Social Science, LL.M., 1999; The George Washington University Law School, LL.M., 2002
Washington Eye Clinic 416 W Las Tunas Dr STE 304, San Gabriel, CA 91776 (626)5882518 (phone)
Education:
Medical School Louisiana State University School of Medicine at New Orleans Graduated: 1998
Procedures:
Lens and Cataract Procedures
Conditions:
Cataract Glaucoma Keratitis Retinal Detachments
Languages:
Chinese English
Description:
Dr. Huang graduated from the Louisiana State University School of Medicine at New Orleans in 1998. He works in San Gabriel, CA and specializes in Ophthalmology. Dr. Huang is affiliated with San Gabriel Valley Medical Center.
H & H SOUTH FLORIDA, LLC Business Services at Non-Commercial Site
43-52 Elbertson St, Elmhurst, NY 11373 43-52 Elbertson St 2, Elmhurst, NY 11373 4352 Elbertson St, Flushing, NY 11373 5857 N University Dr, Fort Lauderdale, FL 33321
Ying Huang Pharmacologist Cber/octgt/dcept/ptb
United States Health and Human Services
1101 Wootton Pkwy STE 600, Rockville, MD 20852
Ying Huang
Cal Stonewood LLC Clothing Dist
241 W 37 St, New York, NY 10018 (646)2486870
Ying Wei Huang
FUJIYAMA BROADVIEW HTS., INC
Ying Huang
Huang, Dr. Ying M Pediatrician
3444 Ellicott Ctr Dr, Ellicott City, MD 21043 (410)7502229
Oct 2007 to 2000 Associate AttorneyRobert G. Mazeau Law Firm Hackensack, NJ Jun 2006 to Oct 2007 Associate AttorneyNissenbaum & Associates, LLC Union, NJ Sep 2005 to Jun 2006 Associate AttorneySuperior Court of New Jersey Paterson, NJ Sep 2004 to Aug 2005 Judicial Law Clerk, Hon. Thomas F. Brogan
Education:
Emory University School of Law Atlanta, GA 2004 Juris DoctorBrandeis University Waltham, MA 2000 Bachelor of Arts in Political Science
May 2011 to Jun 2013 Preschool Teacher, Quality Schools International, Ashgabat, TurkmenistanClifton Gunderson LLP Calverton, MD Jul 2005 to May 2007 Audit Associate
Education:
H. Smith School of Business, University of Maryland May 2005 B. S. in Accounting
Jul 2012 to 2000 Statistical ConsultantThe University of Memphis
Sep 2005 to Jul 2012 Lead StatisticianInvestor protection and cash holdings
2012 to 2012Virginia Department of Education
2010 to 2010Supplemental Educational Services
2008 to 2009 StudentReading First on a Rural Appalachian Preschool
Mar 2008 to Mar 2008Huang Y
2008 to 2008Huang Y
2007 to 2008Classrooms, Paper New York, NY 2007 to 2007American Educational Research Association
2007 to 2007meeting of American Educational Research Association Chicago, IL 2007 to 2007Huang Y
2007 to 2007Huang Y
2006 to 2007Huang Y
2006 to 2007Tennessee Reading First Chicago, IL 2006 to 2006Early Reading First
2006 to 2006J. A St. Louis, MO 2006 to 2006The University of Memphis
Jan 2004 to Sep 2005 Research AssistantThe University of Memphis
May 2004 to Sep 2004 Research AssociateRegional Economic Development Center
Jan 2002 to Jan 2004 Research Assistant
Education:
The University of Memphis Memphis, TN Aug 2005 Master of City in PlanningThe University of Memphis Memphis, TN May 2005 Master of Science in StatisticsJiangxi Normal University Nanchang, CN May 2000 Bachelor of Arts in English
Us Patents
Substituted Urea Neuropeptide Y Y5 Receptor Antagonists
William J. Greenlee - Teaneck NJ, US Ying Huang - East Brunswick NJ, US Joseph M. Kelly - Parlin NJ, US Stuart W. McCombie - Caldwell NJ, US Andrew W. Stamford - Chatham Township NJ, US Yusheng Wu - New York NY, US
A novel class of compounds such as antagonists of the neuropeptide Y Y5 receptor, methods of making such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention or amelioration of one or more diseases associated with the neuropeptide Y Y5 receptor are disclosed.
Method And Apparatus For Solution-Template Based Deployment And Management Of An Integration Solution
Hung-yang (Henry) Chang - Scarsdale NY, US Ying Huang - Yorktown Heights NY, US Jim Alain Laredo - Katonah NY, US Jeaha Yang - Stamford CT, US Ray Ming Yeh - Katonah NY, US
Assignee:
International Business Machines Corporation - Armonk NY
International Classification:
G06F 17/00 G06N 5/00
US Classification:
706 45, 706 46, 706 47
Abstract:
A method for automating the deployment and lifecycle management of an integration solution by using a deployment solution template to gather deployment information, where the integration solution combines components developed separately or on different platforms. The deployment information gathered includes the computing environment topology into which the integration solution is being deployed, as well as the resource requirements and non-functional requirements of the integration solution and its components. The method provides computer implemented models for analyzing the gathered deployment information, and identifying and optimizing deployment options. Choices for selection among identified and optimized options based on non-functional requirements of the integration solution may be displayed to a user of the deployment method. The deployment template may be customized to modify the information being gathered in view of the analysis provided by the models, and in order to use the template and models in subsequent deployments and for the management of the integration solution.
Method And Framework For Model Specification, Consistency Checking And Coordination Of Business Processes
Kumar Bhaskaran - Englewood Cliffs NJ, US Guillermo Gallego - Ridgewood NJ, US Ying Huang - Yorktown Heights NY, US Ying T. Leung - Tarrytown NY, US Nitin R. Nayak - Ossining NY, US Sanjay E. Ramaswamy - Naperville IL, US
Assignee:
International Business Machines Corporation - Armonk NY
International Classification:
G06F 9/44
US Classification:
717104, 717105, 705 7, 705 10
Abstract:
A computer implemented system analysis and design method for use in a complex business environment characterized by a set of tightly linked business processes captures in a framework a world view of a business decision and/or a business application software system. A world view is defined by business objectives, constraints, assumptions, data, and underlying model used in business decision and/or the application software system. The framework is used to specify and document each business decision and/or business application software system in the complex environment. A BDML (Business Decision Markup Language) is used to implement the framework for specifying the world view of a business decision and/or a business application software system. A BDML processor comprises a syntax processor that checks the syntax correctness and syntax consistency within an individual and between different documents written in BDML, a logic processor that checks logical consistency between different documents written in BDML, in terms of the business objectives, constraints, assumptions, data, and underlying model among the different documents, and a knowledge-based processor including a knowledge base of business decisions, common choices for their decision support models and commercially available decision support systems, the knowledge-based processor providing suggestions for a set of BDML documents to improve consistency using the knowledge base.
System And Method For Analyzing A Business Process Integration And Management (Bpim) Solution
Kumar Bhaskaran - Englewood Cliffs NJ, US Ying Huang - Yorktown Heights NY, US Santhosh Kumaran - Croton on Hudson NY, US Prabir Nandi - Bayside NY, US Zhong Tian - Beijing, CN Jian Wang - Beijing, CN Jun Zhu - Beijing, CN
Assignee:
International Business Machines Corporation - Armonk NY
International Classification:
G06G 7/48
US Classification:
703 6, 703 22
Abstract:
A system for analyzing a business process integration and management (BPIM) solution includes an assembler which assembles a plurality of solution artifacts to form a platform independent solution template, a simulator which simulates an execution of a BPIM solution based on the platform independent solution template, and an analyzer for analyzing a performance of the BPIM solution.
Yusheng Wu - New York NY, US Ulrich Iserloh - Hoboken NJ, US Jared N. Cumming - Garwood NJ, US Xiaoxiang Liu - River Vale NJ, US Robert D. Mazzola - Stewartsville NJ, US Ying Huang - East Brunswick NJ, US Andrew Stamford - Chatham Township NJ, US Brian McKittrick - New Vernon NJ, US Zhaoning Zhu - Plainsboro NJ, US
Disclosed are compounds of formula IAlso disclosed is the method of inhibiting aspartyl protease, and in particular, the methods of treating cardiovascular diseases, cognitive and neurodegenerative diseases. Also disclosed are methods of treating cognitive or neurodegenerative diseases using the compounds of formula I in combination with a cholinesterase inhibitor or a muscarinic magonist or mantagonist.
Device To Treat And/Or Prevent Shoulder Subluxation
Ying Chi Huang - Flushing NY, US Manuj Agarwal - Fresh Meadows NY, US
International Classification:
A61F 5/00
US Classification:
602 13, 602 4
Abstract:
A device intended to provide stabilization of a subluxed joint through a pneumatic air chamber combined with a plurality of straps designed to provide ease of use to the patient with a subluxed shoulder joint. This pneumatic sling will allow the user to operate this device with one upper extremity and improves independence to this population. The combination of the air chamber to the sling will provide added comfort by conforming to the discrepancies of an individual's body contours. The design of this invention with the manual pump and release valve will allow the ease of donning and doffing the device.
Tirthankar Bandyopadhyay - Elmsford NY, US Kumar Bhaskaran - Englewood Cliffs NJ, US Rajesh Chopra - Union NJ, US Christina Derra - Düsseldorf, DE Shiwa Fu - Chappaqua NY, US Ying Huang - Yorktown Heights NY, US Stephen K. Kibby - Carlsbard CA, US Santhosh Kumaran - Peekskill NY, US Igor A. Naumov - Plano TX, US Thomas D. Rosinski - Frisco TX, US Gerhard Sigl - Hudson NH, US
Assignee:
International Business Machines Corporation - Armonk NY
International Classification:
G06F 9/44
US Classification:
717121
Abstract:
A method for configuring a software package for an enterprise includes gathering desired To-be configuration requirements for a software package through at least one questionnaire; gathering current As-Is raw data for the enterprise; displaying the To-Be configuration requirements and As-Is raw data; comparing the To-Be configuration requirements and As-Is raw data; selecting final To-Be configuration requirements; and generating and executing configuration code for the software package to pre-configure the software package with the final To-Be configuration requirements.
Yusheng Wu - New York NY, US Ulrich Iserloh - Hoboken NJ, US Jared N. Cumming - Garwood NJ, US Xiaoxiang Liu - River vale NJ, US Robert D. Mazzola - Stewartsville NJ, US Ying Huang - East Brunswick NJ, US Andrew Stamford - Chatham NJ, US Brian McKittrick - New Vernon NJ, US Zhaoning Zhu - Plainsboro NJ, US
Disclosed are compounds of formula IAlso disclosed is the method of inhibiting aspartyl protease, and in particular, the methods of treating cardiovascular diseases, cognitive and neurodegenerative diseases. Also disclosed are methods of treating cognitive or neurodegenerative diseases using the compounds of formula I in combination with a cholinesterase inhibitor or a muscarinic magonist or mantagonist.
Reference: Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial by Feng-Cai Zhu, Xu-Hua Guan, Yu-Hua Li, Jian-Ying Huang, Tao Jiang, Li-Hua Hou, Jing-Xin Li, Be
Date: Jul 20, 2020
Category: More news
Source: Google
Gilead Sciences, Inc Stock May Be in For a Rally Ahead of EASL
According to Merrill Lynch analyst Ying Huang who has also commented on the published abstracts Gileads 24-week sof/vel combo drug with or without ribavirin delivered a retreatment option for patients who failed initial treatment with the same combo med for 8-12 weeks. An 8-week triple combinat
Date: Apr 01, 2016
Category: Business
Source: Google
Cost of Gilead's hepatitis C pill, Sovaldi, spurs revolt
"It's just the sheer number of patients who have the disease. Multiply that number by that price," said Ying Huang, a senior biotechnology analyst at Barclays, whose clients include Gilead. "All of a sudden, you get a big number."
approved in 100 countries for kidney cancer and liver cancer, are split between Bayer and Onyx. The drug had sales of roughly $900 million last year. An expanded approval for thyroid cancer could result in an additional $300 million in peak global sales annually, said Ying Huang, a Barclays analyst.
Date: Jun 02, 2013
Category: Health
Source: Google
GlaxoSmithKline extends tender offer for Human Genome Sciences
"We continue to believe the most likely outcome will be a slightly higher bid from GSK, with no white knights coming to the table with a substantially higher bid," said Ying Huang and Brian Bourdot at Barclays Capital.